We are live on ! Find out more
OI

Oakbrook Investments Portfolio holdings

AUM $39.2M
1-Year Est. Return 3.66%
This Fund
S&P 500
This Quarter Est. Return
+4.64%
1 Year Est. Return
-3.66%
3 Year Est. Return
+26.09%
5 Year Est. Return
+53.43%
10 Year Est. Return
AUM
$1.67B
AUM Growth
+$19.5M
Cap. Flow
-$41.4M
Cap. Flow %
-2.49%
Top 10 Hldgs %
26.31%
Holding
679
New
75
Increased
199
Reduced
296
Closed
84

Top Buys

Rank Stock Value
1
HD icon
Home Depot
HD
+$19.4M
2
LLY icon
Eli Lilly
LLY
+$4.87M
3
MRK icon
Merck
MRK
+$4.39M
4
TJX icon
TJX Companies
TJX
+$3.57M
5
ABT icon
Abbott
ABT
+$3.1M

Top Sells

Rank Stock Value
1
MKC icon
McCormick & Company Non-Voting
MKC
+$19.3M
2
ADSK icon
Autodesk
ADSK
+$4.36M
3
XOM icon
ExxonMobil
XOM
+$4.07M
4
T icon
AT&T
T
+$3.71M
5
SPGI icon
S&P Global
SPGI
+$3.33M

Sector Composition

Rank Sector Weight
1 Technology 16.22%
2 Healthcare 15.27%
3 Financials 14.58%
4 Consumer Discretionary 12.76%
5 Consumer Staples 10.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LKQ icon
426
LKQ Corp
LKQ
$6.19B
$423K 0.03%
+15,900
New +$445K
LW icon
427
Lamb Weston
LW
$7.16B
$422K 0.03%
6,666
+150
+2% +$9.89K
KRC icon
428
Kilroy Realty
KRC
$4.34B
$417K 0.03%
5,650
+200
+4% +$15.2K
TWLO icon
429
Twilio
TWLO
$29.3B
$416K 0.03%
3,050
+700
+30% +$93.2K
NBIX icon
430
Neurocrine Biosciences
NBIX
$16.2B
$414K 0.02%
4,900
+2,400
+96% +$197K
JAZZ icon
431
Jazz Pharmaceuticals
JAZZ
$16.7B
$413K 0.02%
2,900
+1,400
+93% +$188K
LPT
432
DELISTED
Liberty Property Trust
LPT
$413K 0.02%
8,250
+100
+1% +$4.89K
EXAS
433
DELISTED
Exact Sciences
EXAS
$410K 0.02%
3,475
+375
+12% +$37.8K
CW icon
434
Curtiss-Wright
CW
$26.4B
$407K 0.02%
3,200
-1,550
-33% -$179K
EVR icon
435
Evercore
EVR
$11.9B
$407K 0.02%
4,600
-250
-5% -$22.3K
BALL icon
436
Ball Corp
BALL
$16.7B
$406K 0.02%
+5,800
New +$360K
OZK icon
437
Bank OZK
OZK
$5.63B
$406K 0.02%
+13,500
New +$418K
UMPQ
438
DELISTED
Umpqua Holdings Corp
UMPQ
$406K 0.02%
24,500
+2,500
+11% +$42.3K
CLH icon
439
Clean Harbors
CLH
$16.2B
$405K 0.02%
5,700
+1,300
+30% +$90.5K
LOGM
440
DELISTED
LogMein, Inc.
LOGM
$405K 0.02%
5,500
-550
-9% -$42.5K
ICUI icon
441
ICU Medical
ICUI
$4.16B
$403K 0.02%
1,600
-275
-15% -$63.7K
QRVO icon
442
Qorvo
QRVO
$8.41B
$403K 0.02%
6,050
-270
-4% -$18.8K
LNG icon
443
Cheniere Energy
LNG
$54.9B
$387K 0.02%
5,650
KIM icon
444
Kimco Realty
KIM
$16.4B
$381K 0.02%
20,591
-605
-3% -$11K
CZR
445
DELISTED
Caesars Entertainment Corporation
CZR
$379K 0.02%
32,100
MPT
446
Medical Properties Trust
MPT
$2.75B
$378K 0.02%
21,700
+1,300
+6% +$23.4K
EXEL icon
447
Exelixis
EXEL
$12.9B
$377K 0.02%
17,650
-18,950
-52% -$397K
ASH icon
448
Ashland
ASH
$3.32B
$376K 0.02%
4,700
-900
-16% -$69.5K
RRX icon
449
Regal Rexnord
RRX
$11.9B
$368K 0.02%
4,500
+100
+2% +$8.05K
LPLA icon
450
LPL Financial
LPLA
$28.3B
$367K 0.02%
4,500

Similar funds

Oakbrook Investments's Q2 2019 Portfolio in Review

As of Q2 2019, Oakbrook Investments held 679 positions worth $1.67B, up 1.2% from $1.65B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Oakbrook Investments's Q2 2019 filing shows 75 new, 199 increased, 296 reduced and 84 closed positions. Its largest new stake was Progressive: 39,300 shares worth $3.14M. The largest sale was McCormick & Company Non-Voting, an estimated $19.3M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • Oakbrook Investments's largest Q2 2019 buy was Progressive: 39,300 shares worth $3.14M.
  • Oakbrook Investments added most to Home Depot in Q2 2019, an estimated $19.4M increase.
  • Oakbrook Investments's biggest Q2 2019 reduction was McCormick & Company Non-Voting, cutting an estimated $19.3M.
  • Oakbrook Investments fully exited S&P Global in Q2 2019, selling an estimated $3.33M.
  • Oakbrook Investments's ten largest holdings make up 26% of its $1.67B portfolio in Q2 2019.
  • Oakbrook Investments opened 75 new positions and closed 84 in Q2 2019.
  • Oakbrook Investments's portfolio value rose 1.2% quarter-over-quarter to $1.67B.

Based on Oakbrook Investments's 13F filing for Q2 2019, filed 18 Jul 2019.